FDA: Consumer Electronics May Impact Implanted Medical Devices
The FDA is advising patients with implanted medical devices to consider keeping consumer electronics at least 6 inches away from the implanted medical device.
The FDA is advising patients with implanted medical devices to consider keeping consumer electronics at least 6 inches away from the implanted medical device.
The Clinical Trials Subcommittee of the IHS penned this statement to facilitate the development of an evidence base for new medications and devices for migraine treatment.
The restoration of neural sensory feedback in patients with transfemoral amputations was found to improve confidence, walking speed, and mental and physical fatigue.
In meta-analysis, sensitivity, specificity comparable for deep learning models and health care professionals
Canadian researchers are examining the potential for immersive virtual reality to provide prolonged analgesia in patients with chronic pain.
Electronic and mobile technologies may provide short- and intermediate-term improvements in pain intensity for patients with chronic pain.
The use of a smartphone-based progressive muscle relaxation was found to be associated with a reduction in monthly headache days and depression scores in patients with migraine.
Reductions in pain scores in patients with fibromyalgia who used a minimally invasive Angel Touch device for 8 weeks were found in meta-analyses to be comparable to those reported by patients treated with drugs for the condition.
A virtual reality treatment developed for the treatment of phantom limb pain may reduce pain intensity and phantom sensations in some patients.
Drake and colleagues blamed rural America’s poor access of health care on inadequate broadband service; however, Struminger and Arora questioned their theory that deficient Internet availability leads to a reduction in telemedicine in rural areas.